drugset / Trial / NCT04465929

Expanded Access - Autologous Human Schwann Cells in Peripheral Nerve Repair

NCT04465929 ↗

Expanded access No longer available W. Dalton Dietrich

Summary

Emergency expanded access for a single patient was granted to receive autologous human Schwann cell (ahSC) augmentation of nerve autograft repair after severe peripheral nerve injury (PNI).

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Human Schwann Cells Cell therapy — Other